Sinovac Costs More, Less Effective Based On Data

Sinovac Costs More But Is Less Effective Than Other Vaccines According to Data

SINOVAC VACCINE LESS EFFECTIVE – China’s leading COVID-19 vaccine, Sinovac, was found to have a 50% efficacy rate but costs more than other vaccines.

As 2021 comes to a close, several vaccine candidates against COVID-19 were developed. Among the leading brands were Pfizer and Moderna’s COVID-19 vaccines.

However, the Philippines’ Vaccine Czar emphasized that the government was prioritizing China’s Sinovac Vaccine which had a 50% efficacy rate. According to the DOST, this was acceptable as it passed the World Health Organizations’ minimum requirements.

Sinovac Costs More, Less Effective Based On Data - Vaccine Comparison

Still, with such a low efficacy rating, Sinovac is still the second-most expensive vaccine next to Moderna which showed 95% effectiveness against COVID-19.

According to an article from ABS-CBN, here are the estimated prices of vaccines inclusive of 12% vat, 10% inflation rate:

Vaccine	Doses	Total Price (inclusive of 12% vat, 10% inflation rate)	Efficacy Rate	# Of Recipients (For P82.5B)
Astrazeneca	2	610	90%	135,245,901
Novavax	2	366	95%	225,409,836
Pfizer	2	2,379	95%	34,678,436
Moderna	2	3,904-4,504	94%	18,317,051 – 21,132,172
Sinovac	2	3,629	50%	22,730,403
Gamaleya	2	1,220	90%	67,622,950
Covavax	2	854	95%	96,604,215

Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.

What do you think about this? Leave a comment below!